Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 72,902 | 68,355 | 69,640 | 65,474 | 69,320 |
| Cost of Goods | 23,621 | 43,152 | 23,053 | 20,278 | 19,427 |
| Gross Profit | 49,281 | 25,203 | 46,587 | 45,196 | 49,893 |
| Operating Expenses | 52,363 | 46,220 | 53,084 | 47,728 | 51,133 |
| Operating Income | -2,461 | -20,865 | -6,444 | -2,254 | -813 |
| Interest Expense | 1,859 | 1,601 | 1,733 | 1,868 | 1,884 |
| Other Income | 326 | 338 | 277 | 300 | 91 |
| Pre-tax Income | -3,994 | -22,128 | -7,900 | -3,822 | -2,606 |
| Income Tax | -21 | 36 | 58 | 32 | -108 |
| Net Income Continuous | -3,973 | -22,164 | -7,958 | -3,854 | -2,498 |
| Net Income | $-3,973 | $-22,164 | $-7,958 | $-3,854 | $-2,498 |
| EPS Basic Total Ops | -0.12 | -0.59 | -0.21 | -0.10 | -0.06 |
| EPS Basic Continuous Ops | -0.11 | -0.59 | -0.21 | -0.10 | -0.07 |
| EPS Diluted Total Ops | -0.12 | -0.59 | -0.21 | -0.10 | -0.07 |
| EPS Diluted Continuous Ops | -0.11 | -0.59 | -0.21 | -0.10 | -0.06 |
| EBITDA(a) | $1,941 | $-16,446 | $-2,086 | $2,053 | $3,448 |